Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy

CA Miller, J Sarma, JH Naish, N Yonan… - Journal of the American …, 2014 - jacc.org
CA Miller, J Sarma, JH Naish, N Yonan, SG Williams, SM Shaw, D Clark, K Pearce, M Stout…
Journal of the American College of Cardiology, 2014jacc.org
Objectives: This study sought to evaluate the diagnostic performance of multiparametric
cardiovascular magnetic resonance (CMR) for detecting cardiac allograft vasculopathy
(CAV) using contemporary invasive epicardial artery and microvascular assessment
techniques as reference standards, and to compare the performance of CMR with that of
angiography. Background: CAV continues to limit the long-term survival of heart transplant
recipients. Coronary angiography has a Class I recommendation for CAV surveillance and …
Objectives
This study sought to evaluate the diagnostic performance of multiparametric cardiovascular magnetic resonance (CMR) for detecting cardiac allograft vasculopathy (CAV) using contemporary invasive epicardial artery and microvascular assessment techniques as reference standards, and to compare the performance of CMR with that of angiography.
Background
CAV continues to limit the long-term survival of heart transplant recipients. Coronary angiography has a Class I recommendation for CAV surveillance and annual or biannual surveillance angiography is performed routinely in most centers.
Methods
All transplant recipients referred for surveillance angiography at a single UK center over a 2-year period were prospectively screened for study eligibility. Patients prospectively underwent coronary angiography followed by coronary intravascular ultrasound, fractional flow reserve, and index of microcirculatory resistance. Within 1 month, patients underwent multiparametric CMR, including assessment of regional and global ventricular function, absolute myocardial blood flow quantification, and myocardial tissue characterization. In addition, 10 healthy volunteers underwent CMR.
Results
Forty-eight patients were recruited, median 7.1 years (interquartile range: 4.6 to 10.3 years) since transplantation. The CMR myocardial perfusion reserve was the only independent predictor of both epicardial (β = −0.57, p < 0.001) and microvascular disease (β = −0.60, p < 0.001) on stepwise multivariable regression. The CMR myocardial perfusion reserve significantly outperformed angiography for detecting moderate CAV (area under the curve, 0.89 [95% confidence interval (CI): 0.79 to 1.00] vs. 0.59 [95% CI: 0.42 to 0.77], p = 0.01) and severe CAV (area under the curve, 0.88 [95% CI: 0.78 to 0.98] vs. 0.67 [95% CI: 0.52 to 0.82], p = 0.05).
Conclusions
CAV, including epicardial and microvascular components, can be detected more accurately using noninvasive CMR-based absolute myocardial blood flow assessment than with invasive coronary angiography, the current clinical surveillance technique.
jacc.org
以上显示的是最相近的搜索结果。 查看全部搜索结果